Global Bone Cement Market

Bone Cement Market Size, Share, Growth Analysis, By Product(Polymethyl Methacrylate (PMMA) Cement, Glass Polyalkenoate Cement, Calcium Phosphate Cement), By Application(Arthroplasty (Total Knee Arthroplasty, Total Shoulder Arthroplasty, Total Hip Arthroplasty), Others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2690 | Region: Global | Published Date: October, 2024
Pages: 157 | Tables: 63 | Figures: 75

Bone Cement Market Dynamics

Bone Cement Market Drivers 

Growing Prevalence of Orthopedic Disorders 

  • The growing prevalence of orthopedic conditions like osteoarthritis, osteoporosis, and fractures are some of the substantial drivers for the bone cement market. With the global aging population, the demand for joint replacement surgeries is rapidly increasing, driving the requirement for bone cement. Furthermore, PMMA cement is massively utilized in procedures such as high and knee arthroplasties, improving the stability of implant.  

Growing Demand of Spinal Procedures 

  • In recent times, the number of spinal disorders has immensely increased, which includes vertebral compression fractures and degenerative disc problems, boosting the bone cement market. Common processes that are used for treating spinal fractures are vertebroplasty and kyphoplasty. These immensely depends on bone cement for stabilization and pain relief. Moreover, technological advancements in cement formulations have enhanced results, making such processes more dependable.  

Bone Cement Market Restraints 

Strict Regulatory Approvals  

  • The bone cement market has to deal with huge difficulties because of strict regulatory frameworks and long approval procedures. The regulatory bodies like FDA and EMA have implemented stringent clinical trials and compliance along with safety standards that are delaying the launches of the products. Such situations frequently discourage many small organizations from venturing into the market owing to the high expenses related to research and development.  

Possible Side Effects and Complications 

  • The possibilities of complications related with bone cement like bone cement implantation syndrome has increased concerns among many medical professionals and patients. BCIS shows symptoms such as hypoxia and cardiac arrest, that can happen during or after the surgeries with cement. Moreover, allergic reactions and local tissue damages have also been reported in some of the cases. These factors are discouraging many medical providers and patients the use of bone cement. 

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Bone Cement Market size was valued at USD 1.1 billion in 2022 and is poised to grow from USD 1.16 billion in 2023 to USD 1.84 billion by 2031, growing at a CAGR of 5.9% during the forecast period (2024-2031).

The bone cement industry is highly competitive with top players such as Stryker Corporation, Zimmer Biomet, and Heraeus Medical dominating the field. These companies are focusing on more innovative cement formulations with improved biocompatibility and minimized exothermic reaction. The common strategy to increase market footprints and improve the product portfolio is through collaboration, mergers and acquisitions. New entrants are also gaining market share, especially in emerging markets, by using cost advantage and local expertise. Moreover, the R&D expenditure is fueled by rise of personalized and patient-specific options. The competitive landscape is characterized by technological innovation, alliances, and unmet clinical needs for a given disease space.  'Stryker (US) ', 'Merck KGaA (Germany) ', 'Johnson & Johnson (Depuy Synthes) (US) ', 'Zimmer Biomet (US) ', 'Smith & Nephew (UK) ', 'Arthrex, Inc. (US) ', 'Exactech (US ) ', 'Heraeus Holding (Germany) ', 'Cardinal Health (US) ', 'B. Braun Melsungen AG (Germany) ', 'Medtronic plc (Ireland) ', 'Geuder AG (Germany) ', 'NuVasive, Inc. (US) ', 'Heraeus Medical GmbH (Germany) ', 'Curasan AG (Germany) ', 'Biometrix (US) ', 'Siora Surgicals Pvt. Ltd. (India) ', 'Promedics Orthopaedics (US) ', 'Synthes GmbH (Switzerland) ', '3M Company (US) ', 'OsteoMed LLC (US) ', 'Elekta AB (Sweden) ', 'Surgical Specialties Corporation (Canada)'

Advent of Antibiotic-Loaded Bone Cement: The advancement of antibiotic-loaded bone cements is a growing bone cement market trend. This addresses the dual requirement for infection control and structural support in orthopedic surgeries. Such formulations can release antibiotics locally, minimizing the risk of post-surgical infections without side effects. This innovation is extremely beneficial for high-risk processes like joint replacements in patients with diabetes or immune disorders.  

North America is dominating with the largest bone cement market share. The growth in this region is due to availability of developed healthcare infrastructure and implementation of high penetration of advanced medical devices in this region. The largest contributor in the region is USA, driven by its massive ageing population plus a rise in joint-related disorders including arthritis. Many R&D activities focus on the advancement of bone cement compositions that can minimize the post-operative complications. Furthermore, an increase in the number of outpatient surgeries and high preference for minimally invasive surgeries is driving the market growth. Continuous advancement of technology, ensure that North America continues to lead the global bone cement market. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Bone Cement Market

Report ID: SQMIG35A2690

$5,300
BUY NOW GET FREE SAMPLE